I Do Hate To Tell You This, But. . .

The timing of this report from the FDA is surely no accident, but it’s always a good time to think about this: the great majority of all drugs that enter clinical trials fail. They fail because they don’t do anyone any good, or because what good they might do is outweighed by some serious and … Continue reading I Do Hate To Tell You This, But. . .